1. Volume 3, Issue 4, Pages 322-325 (July 2017)
Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroids 
John W. Roman, MD, Michelle A. Ojemuyiwa, MD, Lisa M. Cordes, PharmD, Ravi A. Madan, MD, Leonard Sperling, MD 
JAAD Case Reports 
Volume 3, Issue 4, Pages (July 2017)
DOI: /j.jdcr
Copyright © Terms and Conditions

2. Fig 1 Clinical extravasation 3 weeks after docetaxel infusion.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © Terms and Conditions

3. Fig 2
A, Epidermal changes. B, Overview of dermal changes. (Original magnifications: A, ×200; B, ×100.)
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © Terms and Conditions

4. Fig 3
Intralesional steroid approach. The x represents areas of injection. The oval represents the untreated area.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © Terms and Conditions

5. Fig 4
Resolution of the proximal affected skin 3 weeks after treatment with distal untreated area largely unchanged.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © Terms and Conditions

6. Fig 5
Three weeks after final treatment of distal region with intralesional steroids and treatment of entire region with topical clobetasol ointment. No induration or firmness with only postinflammatory hyperpigmentation on examination.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr )
Copyright © Terms and Conditions